Grande estudo genético descobre novos alvos terapêuticos para o Alzheimer

01 de junho de 2026

Reportado por IA

Uma grande análise de dados genéticos relacionou 127 localizações genéticas à doença de Alzheimer, incluindo 48 que não haviam sido identificadas anteriormente. Os pesquisadores também apontaram diversos genes como alvos promissores para medicamentos e destacaram alterações nas células imunes e nervosas.

O estudo examinou informações do genoma de quase 110.000 pessoas diagnosticadas com Alzheimer e outras 74.000 que tinham um dos pais com a condição. Esses dados foram comparados com informações de 2,6 milhões de pessoas sem a doença. Esse esforço identificou 127 localizações genéticas associadas, sendo 48 delas novas descobertas.

Artigos relacionados

Scientists call for multi-pronged strategies against Alzheimer's

A team of researchers led by Professor Yan-Jiang Wang has published a review arguing that Alzheimer's disease requires integrated treatments targeting multiple factors, not single causes. New drugs like lecanemab and donanemab offer modest benefits by slowing decline, but fall short of reversal. The paper, in Science China Life Sciences, emphasizes genetics, aging, and systemic health alongside amyloid-beta and tau proteins.

USC researchers identify compounds targeting Alzheimer’s brain inflammation

26 de maio de 2026 Reportado por IA

Scientists at the University of Southern California have found experimental compounds that may reduce harmful brain inflammation associated with Alzheimer’s disease. The work focuses on the enzyme cPLA2 and people who carry the high-risk APOE4 gene.

Mechanic with Alzheimer's mutation avoids disease through heat exposure

Doug Whitney, a US mechanic carrying a genetic mutation that typically triggers early-onset Alzheimer’s disease, has reached his late 70s without symptoms. Researchers link his protection to decades of intense heat exposure in ship engine rooms. The case bolsters evidence that heat therapy may safeguard the brain against the condition.

Nanoparticles reduced amyloid-β and improved cognition in an Alzheimer’s mouse model, researchers report

17 de maio de 2026 Reportado por IA Verificado

Researchers from the Institute for Bioengineering of Catalonia and collaborating institutions report that engineered “supramolecular” nanoparticles restored aspects of blood-brain barrier function in Alzheimer’s-model mice, rapidly lowering brain amyloid-β and producing improvements on behavioral and memory tests.

quarta-feira, 20 de maio de 2026, 20:53h

Grande estudo genético descobre novos alvos terapêuticos para o Alzheimer

Artigos relacionados

Scientists call for multi-pronged strategies against Alzheimer's

USC researchers identify compounds targeting Alzheimer’s brain inflammation

Mechanic with Alzheimer's mutation avoids disease through heat exposure

Nanoparticles reduced amyloid-β and improved cognition in an Alzheimer’s mouse model, researchers report

Study finds alzheimer's risk factors hit women harder

Indiana university team targets idol enzyme to treat alzheimer's

Cochrane review questions benefits of anti-amyloid Alzheimer’s drugs

Scientists restore memory in Alzheimer's mice by blocking PTP1B

New blood test spots Alzheimer's via protein shape changes

Este site usa cookies